← Leaderboards
Paul Konopelsk
Ctis, Inc.
$50,237,380
Attributed
$50,237,380
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $14.2M · FY2015–18$20M$15M$10M$5M$0
'15
'16
'17
'18
Funding mix
By agency
NIH$50,237,380 · 1
By mechanism
N01$27,297,561 · 1
N03$22,939,819 · 1
Top collaborators
No co-investigators on record.
Most similar at Ctis, Inc.
Same institution · by research overlap
- Sudhir Raju$162,951,242
- Kweisi Mfume$13,500,000
- Arti C Patel$381,877
- Lawrence Lessin$332,261
- Arnold Sewall$100,524
Others in their field
Top investigators on “Cancer Therapy Evaluation Program”
- David Heimbrook · Leidos Biomedical Research, Inc.$309,543,556
- Charles A Coltman · Southwest Oncology Group$170,763,900
- Sudhir Raju · Ctis, Inc.$162,951,242
- Norman Wolmark · Nsabp Foundation, Inc.$144,396,654
- Peter J O'Dwyer · University Of Pennsylvania$121,259,702
- Larry Arthur$118,483,032
Research focus
Cancer Therapy Evaluation ProgramContractsMaintenanceSupport SystemTelecommunications
Grant awards (4)
IT AND TELECOM- OTHER IT AND TELECOMMUNICATIONS$13,129,858
N01 · FY2018 · CA · contact PI
IT AND TELECOM- OTHER IT AND TELECOMMUNICATIONS$14,167,703
N01 · FY2017 · CA · contact PI
IT AND TELECOM- OTHER IT AND TELECOMMUNICATIONS$12,189,363
N03 · FY2016 · OD · contact PI
IT AND TELECOM- OTHER IT AND TELECOMMUNICATIONS$10,750,456
N03 · FY2015 · OD · contact PI